Free tool
Drug Search
Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.
Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations
8 matches for "Shionogi"
Brand names that start with your search come first, then marketed and novel drugs.
| Drug | Sponsor | Application | First approved | Programs |
|---|---|---|---|---|
| Xocova Ensitrelvir | Shionogi | NDA220442 | May 29, 2026 | Novel |
| Fetroja Cefiderocol Sulfate Tosylate | Shionogi | NDA209445 | Nov 14, 2019 | NovelPriority review |
| Radicava Ors Edaravone | Shionogi | NDA215446 | May 12, 2022 | Priority reviewOrphan |
| Cognex Tacrine Hydrochloride | Shionogi INC | NDA020070 | Sep 9, 1993 | NovelPriority reviewDiscontinued |
| Ulesfia Benzyl Alcohol | Shionogi | NDA022129 | Apr 9, 2009 | NovelDiscontinued |
| Doribax Doripenem | Shionogi | NDA022106 | Oct 12, 2007 | NovelDiscontinued |
| Radicava Edaravone | Shionogi | NDA209176 | May 5, 2017 | NovelOrphanDiscontinued |
| Rybix Odt Tramadol Hydrochloride | Shionogi INC | NDA021693 | May 5, 2005 | Discontinued |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.